PGHH.BO(PGHH.BO)
PGHH.BO
No analyst ratings available
No analyst price targets available for PGHH.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $47.68B | $50.64B | $54.36B |
| Low | $46.63B | $49.52B | $53.16B |
| High | $48.73B | $51.75B | $55.55B |
| EBITDA Avg | $11.87B | $12.61B | $13.53B |
| Low | $11.61B | $12.33B | $13.23B |
| High | $12.13B | $12.88B | $13.83B |
| EBIT Avg | $11.29B | $11.99B | $12.87B |
| Low | $11.04B | $11.73B | $12.59B |
| High | $11.54B | $12.26B | $13.16B |
| Net Income Avg | $9.48B | $9.86B | $11.05B |
| Low | $9.45B | $9.58B | $10.73B |
| High | $9.50B | $10.14B | $11.36B |
| EPS Avg | $292.00 | $303.70 | $340.30 |
| Low | $291.26 | $295.00 | $330.55 |
| High | $292.73 | $312.40 | $350.05 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $12.67B | $13.51B | $10.95B |
| Low | $12.67B | $13.51B | $10.95B |
| High | $12.67B | $13.51B | $10.95B |
| EBITDA Avg | $3.15B | $3.36B | $2.73B |
| Low | $3.15B | $3.36B | $2.73B |
| High | $3.15B | $3.36B | $2.73B |
| EBIT Avg | $3.00B | $3.20B | $2.59B |
| Low | $3.00B | $3.20B | $2.59B |
| High | $3.00B | $3.20B | $2.59B |
| Net Income Avg | $2.45B | $2.82B | $2.05B |
| Low | $2.45B | $2.82B | $2.05B |
| High | $2.45B | $2.82B | $2.05B |
| EPS Avg | $75.40 | $86.90 | $63.10 |
| Low | $75.40 | $86.90 | $63.10 |
| High | $75.40 | $86.90 | $63.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |